Liangzou

This early study tests a new treatment called CD19 CAR-T cell therapy for people with severe autoimmune diseases like lupus, Sjogren's syndrome, and scleroderma that haven't improved with standard treatments. The therapy uses a patient's own immune cells, modified to target and d…